All News

DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age

Ref: GlobeNewswire

Tags: Press Release DBV Allergies Clinical Research (R&D)Viaskin Peanut

Syros Announces Oral Presentation Highlighting Its Drug Discovery Research in Immuno-Oncology at American College of Surgeons Clinical Congress

Ref: Business Wire

Tags: Press Release Syros Pharmaceuticals Pancreatic Cancer Medical Affairs Clinical Research (R&D)ACS

Janssen Receives Two U.S. FDA Approvals For SIMPONI ARIA (golimumab) For The Treatment Of Adults With Active Psoriatic Arthritis Or Active Ankylosing Spondylitis

Ref: PR Newswire

Tags: Press Release J&J Psoriasis Arthritis FDA Regulatory Affairs Marketing & Sales Simponi Aria

Zosano Enters into Common Stock Purchase Agreement with Lincoln Park Capital

Ref: GlobeNewswire

Tags: Press Release Zosano Corporate Affairs

Xencor to Present Final Results from Phase 2 Study of XmAb 5871 in IgG4-Related Disease at American College of Rheumatology (ACR) 2017 Annual Meeting

Ref: PR Newswire

Tags: Press Release Xencor Medical Affairs Clinical Research (R&D)ACR XmAb5871

Merck cuts 1800 sales positions in US, adds 960 jobs in new chronic care sales force

Ref: Philly.com, StreetInsider, Philadelphia Business Journal, The Wall Street Journal, Business Insider

Tags: Top Story Merck & Co. Corporate Affairs

MIV-711 Phase IIa Osteoarthritis Study Data Selected as Late Breaking Abstract at the Annual Meeting of the American College for Rheumatology

Ref: PR Newswire

Tags: Press Release Medivir Arthritis Medical Affairs Clinical Research (R&D)ACR MIV-711

Novel Device Can Detect Barrett’s Oesophagus From Breath Samples

Tags: Conference Dispatch

Prometic presents PBI-4050 and PBI-4547 in Vivo Data at American Association for the Study of Liver Diseases (AASLD) Meeting

Ref: CNW

Tags: Press Release ProMetic Diabetes Medical Affairs Clinical Research (R&D)AASLD PBI-4547 PBI-4050

Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome

Ref: Business Wire

Tags: Press Release Aurinia Pharmaceuticals Lupus Clinical Research (R&D)voclosporin